对于复发性耐火性多发性髓瘤的新疗法在地平线上
Nadine Abdallah1, Shaji K Kumar1
1Division of Hematology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
像venetoclax, iberdomide, mezigdomide和modakafusp alfa这样的新疗法在复发性多发性髓瘤 (MM) 中表现有前途. 这些药物为耐火性疾病患者提供了新的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤 (MM) 经常复发,尽管治疗方面取得了进展.
- 对于患有复发性或耐火性MM的患者,急需有效的治疗方法.
研究的目的:
- 对复发性和耐火性多发性髓瘤的新疗法进行审查.
- 突出这些药物的作用机制和早期临床试验结果.
主要方法:
- 对新型MM药物的早期临床试验数据的审查.
- 药物机制的概述,包括B细胞淋巴瘤2 (Bcl-2) 抑制,脑细胞E3结合酶调节和免疫细胞因子治疗.
主要成果:
- 威尼托克拉克斯在MM患者中表现出活性,这些患者具有特定的遗传标记 (t(11;14) 和/或Bcl-2表达).
- 与现有疗法相比,在重度预治疗的患者中,伊伯多米德和梅齐多米德显示出增强的功效和活性.
- 莫达卡富斯普阿尔法在复发性/耐药性MM中表现出单剂活性.
结论:
- 几种新型药物正在成为复发性/耐药性多发性髓瘤的有希望的治疗方法.
- 这些药物提供了新的治疗途径,针对MM的独特分子途径.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
